Physician profile
Bryan M Feldner
NPI 1548404544
$5,009.59
in general payments reported to CMS, 2019-2025
30 companies · $448 in 2025
The $448 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $999 · 2020: $551 · 2021: $875 · 2022: $931 · 2023: $784 · 2024: $421 · 2025: $448.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,653.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,653.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $2,518.34 | 2019-2025 | Stravix Mesh, Grafix Pl, Grafix |
| Horizon Therapeutics Plc | $389.75 | 2019-2023 | Krystexxa |
| Stryker Corporation | $354.78 | 2019-2025 | Citrefix |
| Zimmer Biomet Holdings, INC. | $352.50 | 2021 | |
| Paratek Pharmaceuticals, INC. | $200.28 | 2022-2025 | Nuzyra |
| Nevro Corp. | $159.46 | 2022-2024 | Senza |
| Wright Medical Technology, INC. | $151.54 | 2019-2020 | |
| Vaporox, INC. | $99.41 | 2023 | Vht-200 Wound Treatment System |
| Mimedx Group, INC. | $91.63 | 2024-2025 | |
| Amgen INC. | $72.49 | 2024-2025 | Krystexxa |
| Bioventus LLC | $64.73 | 2022-2024 | Exogen Ultrasound Bone Healing System |
| Melinta Therapeutics, LLC | $63.52 | 2019 | |
| Nabriva Therapeutics, Plc | $62.53 | 2021-2022 | |
| Depuy Synthes Sales INC. | $47.45 | 2021-2022 | |
| Paragon 28, INC. | $46.24 | 2021-2023 | Gorilla |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $33.24 | 2021-2022 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $32.31 | 2020-2022 | |
| Encore Medical, LP | $29.97 | 2021 | |
| Averitas Pharma INC. | $29.60 | 2024-2025 | Qutenza |
| Aroa Biosurgery Incorporated | $22.98 | 2022 | |
| Orthofix Medical, INC. | $22.51 | 2019-2025 | Physio-Stim |
| Cashflow Solutions, LLC | $22.33 | 2022 | |
| Sandoz INC. | $21.06 | 2020 | |
| Triad Life Sciences INC. | $20.83 | 2022 | |
| Medtronic, INC. | $19.16 | 2022 | |
| Boston Scientific Corporation | $18.95 | 2019 | |
| Abbott Laboratories | $18.75 | 2024 | Eterna |
| Acell, INC. | $16.20 | 2020 | |
| Inari Medical, INC. | $15.59 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Merck Sharp & Dohme LLC | $11.46 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bryan Feldner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.